Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder.

Autor: Montes de Jesus, F.¹ (AUTHOR) f.m.montes.de.jesus@umcg.nl, Dierickx, D.² (AUTHOR), Vergote, V.² (AUTHOR), Noordzij, W.¹ (AUTHOR), Dierckx, R. A. J. O.¹ (AUTHOR), Deroose, C. M.³ (AUTHOR), Glaudemans, A. W. J. M.¹ (AUTHOR), Gheysens, O.⁴ (AUTHOR), Kwee, T. C.⁵ (AUTHOR)

Publikováno v: EJNMMI Research. 3/18/2021, Vol. 11 Issue 1, p1-8. 8p.

Characterization of post-transplant lymphoproliferative disorder with semi-quantitative FDG-PET/CT

Autor: Montes De Jesus, F., Noordzij, W., Kahle, X., Nijland, M., Verschuuren, E., Dierckx, R., Van Der Meerten, T., Van Der Bij, W., Huls, G., Kwee, T., Glaudemans, A.

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 46(1). SPRINGER

Aim/Introduction: One of the most dire complications of hematopoietic stem cell (HSCT) and solid organ transplantation (SOT) is the development of post-transplant lymphoproliferative disorder (PTLD). PTLD compromises a broad spectrum of disorders cla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4a8fac7fa50733fb3153b2c9f9817fee
https://research.rug.nl/en/publications/7975912a-214d-4e61-8276-23e1b1694265

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [ ¹⁸ F]FDG PET/CT.

Autor: Montes de Jesus F; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands., Vergote V; Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands., Dierickx D; Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium., Dierckx RAJO; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands., Tousseyn T; Department of Pathology University Hospitals Leuven, 3000 Leuven, Belgium., Gheysens O; Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium., Kwee TC; Department of Radiology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands., Deroose CM; Department of Nuclear Medicine, University Hospitals Leuven, 3000 Leuven, Belgium., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Jan 19; Vol. 10 (2). Date of Electronic Publication: 2021 Jan 19.

Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.

Autor: Montes de Jesus FM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: f.m.montes.de.jesus@umcg.nl., Kwee TC; Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Kahle XU; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Huls G; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Dierckx RAJO; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Meerten T; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Gheysens O; Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium; Leuven PTLD Group, University Hospitals Leuven, Leuven, Belgium., Dierickx D; Department of Hematology, University Hospitals Leuven, Leuven, Belgium; Leuven PTLD Group, University Hospitals Leuven, Leuven, Belgium., Vergote V; Department of Hematology, University Hospitals Leuven, Leuven, Belgium; Leuven PTLD Group, University Hospitals Leuven, Leuven, Belgium., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2018 Dec; Vol. 132, pp. 27-38. Date of Electronic Publication: 2018 Sep 19.